Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 288,101 | 167,806 | 174,773 | 281,927 | 110,614 |
| Marketable Securities | 106,565 | 147,551 | 154,907 | 56,877 | 20,241 |
| Receivables | 15,584 | 95,539 | 18,267 | 21,919 | 15,353 |
| TOTAL | $417,634 | $418,460 | $354,697 | $366,294 | $150,264 |
| Non-Current Assets | |||||
| PPE Net | 5,539 | 5,895 | 6,257 | 6,641 | 7,028 |
| Investments And Advances | 0 | 11,128 | 3,029 | 0 | 0 |
| Other Non-Current Assets | 49,140 | 50,087 | 51,477 | 53,100 | 186,290 |
| TOTAL | $54,679 | $67,110 | $60,763 | $59,741 | $193,318 |
| Total Assets | $472,313 | $485,570 | $415,460 | $426,035 | $343,582 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,100 | 2,568 | 2,213 | 1,675 | 2,408 |
| Accrued Expenses | 11,252 | 14,644 | 13,029 | 9,718 | 7,906 |
| TOTAL | $31,775 | $38,302 | $37,407 | $54,633 | $31,502 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 149,944 | 150,545 | 145,372 | 146,554 | 146,097 |
| TOTAL | $149,944 | $150,545 | $145,372 | $146,554 | $146,097 |
| Total Liabilities | $181,719 | $188,847 | $182,779 | $201,187 | $177,599 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,553 | 51,493 | 50,672 | 50,361 | 50,001 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -864,560 | -859,627 | -920,651 | -924,266 | -979,101 |
| Other shareholders' equity | -62 | 61 | 32 | -10 | 0 |
| TOTAL | $290,594 | $296,723 | $232,681 | $224,848 | $165,983 |
| Total Liabilities And Equity | $472,313 | $485,570 | $415,460 | $426,035 | $343,582 |